Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Main subject
Type of study
Language
Publication year range
1.
J Physiol Pharmacol ; 65(5): 603-11, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25371519

ABSTRACT

The biological properties of vanadium complexes have become an object of interest due to their therapeutic potential in several diseases. However, the mechanisms of action of vanadium salts are still poorly understood. Vanadium complexes are cofactors for several enzymes and also exhibit insulin-mimetic properties. Thus, they are involved in the regulation of glucose metabolism, including in patients with diabetes. In addition, vanadium salts may also normalize blood pressure and play a key role in the metabolism of the thyroid and of iron as well as in the regulation of total cholesterol, cholesterol HDL and triglyceride (TG) levels in blood. Moreover, in cases of hypoxia, vanadium compounds may improve cardiomyocytes function. They may also exhibit both carcinogenic and anti-cancer properties. These include dose- and exposure-time-dependent induction and inhibition of the proliferation and survival of cancer cells. On the other hand, the balance between vanadium's therapeutic properties and its side effects has not yet been determined. Therefore, any studies on the potential use of vanadium compounds as supplements to support the treatment of a number of diseases must be strictly monitored for adverse effects.


Subject(s)
Vanadium , Animals , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/therapeutic use , Brain/drug effects , Carcinogens/pharmacokinetics , Carcinogens/toxicity , Cardiotonic Agents/pharmacokinetics , Cardiotonic Agents/therapeutic use , Cardiotonic Agents/toxicity , Diabetes Mellitus/drug therapy , Dietary Supplements/toxicity , Heart Diseases/prevention & control , Humans , Hypertension/prevention & control , Lipid Metabolism/drug effects , Neoplasms/drug therapy , Neoplasms/etiology , Neuroprotective Agents/pharmacokinetics , Neuroprotective Agents/therapeutic use , Neuroprotective Agents/toxicity , Vanadium/pharmacokinetics , Vanadium/therapeutic use , Vanadium/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL